FdaApplication
ANDA 211943
Identifiers
- fda_app_no: ANDA211943
Properties
| Property | Value |
|---|---|
| applicant_name | SAPTALIS PHARMACEUTICALS LLC |
| application_type | ANDA |
| approval_date | 2024-07-05 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CYCLOSPORINE | CYCLOSPORINE | 0.05% | EMULSION;OPHTHALMIC |
1 product